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Abstract
Background: The annual number of new human immunodeficiency virus (HIV) infections in the United Kingdom among men
who have sex with men (MSM) has risen, and remains high among heterosexuals. Increasing HIV transmission among MSM is
consistent with evidence of ongoing sexual risk behavior in this group, and targeted prevention strategies are needed for those at
risk of acquiring HIV.
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Objective: The Attitudes to and Understanding of Risk of Acquisition of HIV (AURAH) study was designed to collect information
on HIV negative adults at risk of HIV infection in the United Kingdom, based on the following parameters: physical and mental
health, lifestyle, patterns of sexual behaviour, and attitudes to sexual risk.
Methods: Cross-sectional questionnaire study of HIV negative or undiagnosed sexual health clinic attendees in the United
Kingdom from 2013-2014.
Results: Of 2630 participants in the AURAH study, 2064 (78%) were in the key subgroups of interest; 580 were black Africans
(325 females and 255 males) and 1484 were MSM, with 27 participants belonging to both categories.
Conclusions: The results from AURAH will be a significant resource to understand the attitudes and sexual behaviour of those
at risk of acquiring HIV within the United Kingdom. AURAH will inform future prevention efforts and targeted health promotion
initiatives in the HIV negative population.
(JMIR Res Protoc 2016;5(2):e58)   doi:10.2196/resprot.4873
KEYWORDS
HIV infection; HIV negative; HIV undiagnosed; HIV transmission; HIV testing; men who have sex with men; black Africans;
sexual risk behaviour; health and wellbeing.
Introduction
Background
During 2013, 6000 people were newly diagnosed with human
immunodeficiency virus (HIV) in the United Kingdom (UK),
and the estimated number of people living with HIV in the
United Kingdom was 107,800 by the end of that year [1].
Despite no reported rise in the annual number of new diagnoses
since 2005 in the overall UK population, there is evidence that
HIV incidence is increasing among men who have sex with
men (MSM) [2], and in 2013 the number of new HIV diagnoses
remained high in black African men and women, who constitute
two thirds of all heterosexuals living with HIV in the United
Kingdom [1].
An estimated 38,700 black Africans were living with HIV in
the United Kingdom in 2013. Despite a decline in new diagnoses
among people born in sub-Saharan Africa, black Africans form
the second largest social group affected by HIV in the United
Kingdom [1]. The combination of high prevalence of HIV in
the black African community [1] and the high proportion of
undiagnosed infection as a consequence of late presentation [3]
means that the potential for onward transmission of HIV is high
within this community. Although the proportion of late HIV
diagnoses has declined overall in the last decade, late diagnosis
was highest among black African men (69%) and women (57%)
in 2013 [1]. Research into factors that affect attitudes towards
HIV and access to HIV testing and services is important. The
African Health and Sex survey in 2013-2014 demonstrated a
low level of awareness on HIV prevalence within black African
people living in the United Kingdom, and poor knowledge of
HIV treatment and care availability [4], which may impact on
access to HIV testing services and sexual risk behavior.
Furthermore, previous research into late presentation among
black Africans demonstrated that HIV awareness did not
translate into individual perception of risk or use of services,
and that major structural barriers such as stigma, confidentiality
and migration issues inhibit the uptake of HIV testing and
services [5].
Evidence of ongoing, and likely increasing, HIV transmission
among MSM [1,2,6-8] is consistent with evidence of ongoing
sexual risk behavior in this group and there is evidence that the
prevalence of condomless sex among MSM in the United
Kingdom may have changed over the last few decades. In the
United Kingdom the extensive research carried out in
community-venue and clinic based studies [6,8-15] has indicated
an increase in the prevalence of condomless anal intercourse
among MSM during the late 1990s and early 2000s, coincident
with the widespread introduction and use of successful
combination antiretroviral treatment (ART) for HIV in
developed countries. Research from the United States [16,17]
and Europe [18-21] also describes an increase in diagnoses of
other sexually transmitted infections (STI) over this time. It has
been suggested that the increase in condomless sex that occurred
in the late 1990s in the Western world may now have plateaued
[9], and recent data from NATSAL-3 (a large representative
survey of sexual behavior in the UK general population from
September 2010 to August 2012) described no change in
prevalence of condomless sex or risk perception in MSM over
the last decade [22]. However, the incidence of HIV in MSM
in the United Kingdom appears to have increased [2]. This
increase cannot be explained by changes in HIV testing alone
[23], but would be compatible with a modest ongoing increase
in condomless sex among MSM [2].
Sexual transmission risk arises as a result of perceptions and
behaviors which may differ depending on the HIV serostatus
of individuals. Strategies aimed at reduction of HIV transmission
need to address differences in both HIV positive and negative
individuals’ perceptions, choices, and behaviors [24]. As
increasing evidence shows that a suppressed HIV viral load
(VL) greatly reduces the risk of onward transmission of HIV
to sexual partners [25,26], it is important to consider how this
research might have reached and influenced HIV negative
persons in different ways to those who are HIV positive. The
PARTNER study recently presented transmission estimates of
zero in heterosexuals and MSM for condomless sex where the
positive partner was on suppressive ART, albeit with a high
upper confidence limit in MSM [27]. These data may also
influence HIV negative persons in understanding and perception
of HIV transmission risks. Research from the United States
suggests that HIV negative MSM perceive a number of sexual
practices with HIV positive MSM on ART as less risky than
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with HIV positive MSM who are not on ART [24]. Furthermore,
evidence from Australia has demonstrated that a behavioral
response by MSM to the risk of HIV transmission has evolved
considerably over time [28]. Risk reduction strategies such as
using HIV VL to negotiate condom use [28], serosorting (using
HIV status as a decision-making point in choosing a sexual
partner [29,30]), strategic positioning (choosing a different
sexual position or practice depending on the serostatus of a
partner [31]), negotiated safety (choosing not to use condoms
with a primary partner and establishing specific rules for sex
outside of the primary relationship [32]), and withdrawal are
now commonly used to reduce the risk of transmitting or
acquiring HIV during condomless anal intercourse.
Current data from the United Kingdom that inform on these
themes from the perspective of HIV negative MSM and black
Africans are limited. In particular, information is needed on
HIV testing behavior and preferences, patterns of sexual
behavior, prevalence of specific types of condomless sex (to
capture potential risk reduction strategies), attitudes to
condomless sex with individuals of known and unknown HIV
status, and associations with factors such as mental/general
health, STI history, and alcohol and drug use. Data from the
Attitudes to and Understanding of Risk of Acquisition of HIV
(AURAH) study will contribute to an understanding of how
knowledge of ART and detectable/undetectable VLs among
HIV negative individuals may affect attitudes and perceptions
which lead to condomless sex with partners of unknown and/or
known HIV status in the United Kingdom.
Uptake and frequency of HIV testing among MSM in the United
Kingdom remains inadequate (an estimated 25% never tested
[2]), as it does in black Africans (an estimated 40% never tested
[33]). Therefore, improving efforts to expand testing outside
sexual health clinics is a priority, and it is a key recommendation
from Public Health England to reduce the burden of undiagnosed
HIV in these two groups [1]. The first self-testing HIV kit
featuring a Kitemark (a UK product and service quality
certification) was released in the United Kingdom in April 2015
[34]. Although the majority of HIV tests are currently conducted
in sexual health clinics, emerging evidence suggests that HIV
self-testing is highly acceptable to both MSM and black Africans
in low and high income settings [35,36]. HIV self-testing may
remove some of the barriers around accessing sexual health
services that are experienced by black Africans and MSM, and
may help to improve access to HIV testing. However, there is
a need to assess HIV testing preferences in HIV negative
individuals, given the recent expansion of testing options to
include HIV self-testing [34], and the need to increase HIV
testing in the most at-risk populations in the United Kingdom.
Results from the AURAH study will seek to inform on HIV
testing preferences and acceptability of HIV testing outside of
the traditional sexual health clinic setting.
The AURAH study will allow comparison of HIV negative or
undiagnosed MSM and black Africans with HIV positive
participants from the Antiretrovirals, Sexual Transmission Risk
and Attitudes (ASTRA) study [37], a previous questionnaire
study undertaken in 2011-2012 by the same group. The ASTRA
study focused on patients with HIV under care within the United
Kingdom, and asked many of the same questions as the AURAH
about sexual behavior, attitudes, and health and lifestyle factors.
The ASTRA study aimed to assess sexual risk behaviors, beliefs
about HIV transmission risk, and attitudes towards the use of
early ART in this population [37]. Previous studies have
illustrated high prevalence rates of depression, anxiety, and drug
and alcohol use in MSM [38], whilst black and minority ethnic
groups in the UK’s general population are also more likely to
be diagnosed with mental health problems and experience poor
outcomes from treatment than other ethnic groups [39,40]. There
is some evidence that depression in MSM is associated with
higher levels of condomless sex and higher risk behaviors [41]
but there is limited data on mental health and wellbeing, and
sexual behavior, among MSM or black Africans in the United
Kingdom. Data from the AURAH study will allow insight into
these issues. Furthermore, comparison between HIV positive
and negative individuals in both MSM and black Africans will
help to elucidate the specific effect of HIV and HIV treatments
on health, wellbeing, and lifestyle among MSM and black
Africans.
This paper describes key aspects underlying the AURAH study,
including its rationale, design, methods and response rates. A
description of the participant characteristics is also outlined.
Details of both response rates and participant characteristics
may be of use in the comparison to other studies set in sexual
health clinics or outpatient settings, and inform future design
and planning of subsequent studies. Further publications will
address detailed research questions based on the data collected
from the participants in the AURAH study.
Aims and Objectives
The primary aim of the AURAH study was to assess patterns
of sexual behavior, and attitudes to sexual risk, among HIV
negative adults at risk of HIV infection, and to investigate
associations with demographic, socio-economic, health, and
lifestyle factors.
Study Objectives
The detailed objectives of the AURAH study were to assess the
following in HIV negative (not known to be HIV positive)
sexual health clinic attendees:
1. Levels of recent condomless vaginal or anal sex according
to demographic groups (sexuality, ethnicity).
2. Among those who have had condomless sex, the distribution
of: number of sexual partners, type of partners, knowledge
of HIV status of partners, number of times had condomless
sex, type of condomless sex, and reasons for not using
condom.
3. Among those having condomless sex with partners of
positive or unknown HIV serostatus, the prevalence of
risk-reduction measures such as seropositioning.
4. The prevalence of psychological and physical symptoms
(ie, depression, anxiety) and lifestyle factors (ie, drug and
alcohol use), and whether demographic/social factors,
psychological and physical symptoms, quality of life, and
lifestyle factors are associated with condomless sex.
5. Beliefs regarding the effect of ART in HIV positive
individuals, and undetectable VL, on HIV transmission risk
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(transmission risk beliefs) and the association of such beliefs
with sexual behavior.
6. History of any HIV testing and attitudes to HIV and HIV
medications, including awareness of, and any history of,
taking post-exposure prophylaxis (PEP) and pre-exposure
prophylaxis (PrEP).
7. Attitudes towards testing for HIV in different settings (ie,
sexual health clinic, general practitioner, community based
testing), type of testing (ie, self-sampling, self-testing) and
preferred sample type for HIV self-testing (ie, saliva based
or finger-prick sample of blood).
Methods
Study Design
AURAH was a cross-sectional self-administered questionnaire
study in individuals attending 20 sexual health (Genito-Urinary
Medicine) clinics, in 15 clinical centers (National Health Service
trusts), across the United Kingdom. The recruitment period was
17 months, commencing June 2013.
Population and Setting
AURAH was conducted among individuals attending sexual
health clinics for routine STI and/or HIV testing. The inclusion
criteria were as follows: HIV negative (or undiagnosed) subjects
aged 18 years or over, attending for routine STI or HIV testing
in sexual health clinics. Individuals not known to be HIV
positive at the time of recruitment to AURAH, but testing
positive on that (or a subsequent) clinic visit were retained in
the AURAH sample.
The 20 clinical centers were situated across England, and details
of the locations and clinics are listed in the Acknowledgements
section. The sites were selected on the understanding that they
could provide access to large numbers of HIV negative patients
attending clinics for STI screening and HIV testing, including
the key demographic at risk subgroups in the United Kingdom
(MSM and black Africans). Most clinics were able to provide
a mixed demographic of study participants but a few clinics
recruited large numbers of one type only. For example, the 56
Dean Street clinic and the Mortimer Market Center recruited a
large number of MSM to the study. Similarly, there were other
centers that provided a larger number of black African male
and female participants for the study, including the Greenway
Center, City of Coventry Healthcare Center, and the Sydenham
Center, Barking, London.
Sample Size
The AURAH study adopted a recruitment target of 2000 total
sample size, of which 1000 would be MSM, and 1000
heterosexuals, of whom 600 would be black African. After
calculations the study would have sufficient power to:
1. Ascertain the proportion of individuals who report that they
have had condomless sex in the past 3 months with a partner
of unknown or positive HIV status and that one of the
reasons for this was “I knew there was a risk of
acquiring HIV but I am not so concerned about having the
disease that it made me want to have sex using a condom.”
This would be calculated as a proportion of all study
participants and as a proportion of all participants reporting
condomless sex.
2. Ascertain the proportion of individuals who report that they
have had condomless sex in the past 3 months with a
positive partner who gave a reason as “I thought the risks
of catching HIV were low because my partner was taking
anti-retroviral therapy.”
3. Compare the prevalence of depression on the Patient Health
Questionnaire (PHQ-9) scale [42] between HIV positive
and HIV negative individuals, separately for HIV negative
MSM, heterosexual men and women, and black African
men and women.
For objectives (1) and (2), the planned sample size of 1000
MSM would allow estimation of a 5% prevalence (95% CI
3.65-6.35), a 10% prevalence (95% CI 8.65-11.35), and a 20%
prevalence (95% CI 17.52-22.48). For the planned sample size
of approximately 300 black African men (or women),
prevalences of 5% (95% CI 2.55-7.45), 10% (95% CI 6.60-13.4)
and 20% (95% CI 15.47-24.53) would be estimated.
For objective (3), given approximately 2250 MSM, 200 black
African men and 450 black African women in the ASTRA
sample [37], and assuming a prevalence of depressive symptoms
of 25% among each of these groups, the study would have 80%
power (with 5% 2-sided significance level) and absolute
difference in prevalence of 4.5% for MSM, 10.0% for black
African men, and 8.5% for black African women.
Recruitment
Recruitment to the study took place between June 2013 and
November 2014 during different periods at the 20 clinics. A
flowchart of recruitment procedures for the study is included
(see Figure 1).
Initial recruitment in the clinics was not restricted. Each site
identified specific clinics each week, at which subjects were
recruited, aiming to ensure a reasonably representative study
population. Consecutive subjects attending each clinic were
identified, approached, and invited to take part. It was more
feasible to initially recruit in this unrestricted way, and the intent
was to modify recruitment strategy as necessary to recruit a
sufficient number of MSM and black Africans. After 6 months
of unrestricted recruiting, targeted recruitment was implemented
across all study sites, and clinic staff were asked to identify and
recruit only MSM or those of black ethnicity. Once the
recruitment target of 1000 MSM had been met (11 months into
the study), 15 clinics were asked to concentrate on recruiting
only those known to have specifically black African ethnicity
before finishing recruitment, and the 5 sites that had recruited
the largest number of MSM continued with sole recruitment of
MSM to increase the power for some research questions.
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Figure 1. Flowchart of AURAH clinic recruitment.
Consent
All subjects who were invited to participate were given an
information sheet about the study. Those who agreed to
complete the questionnaire were asked to sign a consent form.
The form included an optional section for participants to provide
details to allow contact regarding study reminders and, in the
future, to invite participants to join future research studies.
Participants were informed that consent to be contacted was
optional but that those who provided contact details would be
entered into a monthly draw offering a prize of £100 of shopping
vouchers. Participants who agreed to be contacted were asked
for their preferred contact details (email address and mobile
phone number for short message service contact). The consent
form noted that participants’ contact details would only be used
for these purposes and would be held securely at the study
management center as part of the study records, but would be
deleted after a period of two years. During the consent process,
it was reiterated that the study was for HIV negative or
undiagnosed individuals only. Participants were told that the
questionnaire would take between 15 and 30 minutes to
complete and were given an envelope to seal it in, so that their
answers were not available to clinic staff. There was an option
for participants to take the questionnaire off-site for completion,
and postage paid envelopes were provided to return the
questionnaire directly to the study management center if
required. The option of taking the questionnaire off-site was
aimed at including participants who did not have time to
complete the questionnaire before they were called for their
clinic appointment. Participants were encouraged to complete
the questionnaire on-site if possible, to minimize non-return of
questionnaires by consented participants.
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Clinical Data
Participants were made aware that their participation included
supplying information on the results of any STI or HIV tests
that took place in the clinic on the day they were enrolled in to
the study. The study log was used to record whether any HIV
or STI tests were undertaken and to record the result of any HIV
test (negative/positive) performed on the day of enrolment.
Data Processing
Completed questionnaires were collected in the clinic and
transferred regularly to the study management center.
Questionnaires were identified only by a unique study number.
Participants were instructed not to write their name or clinic
number on the questionnaire to maintain their anonymity.
Details of all clinic attendees approached for the study were
collected in a study log maintained securely and updated daily
at each clinical site. The study log contained study numbers,
clinic identifiers and details of consent status for all patients
invited to participate in the study, whether or not HIV and other
STI tests had been done, and the result of any HIV test. Contact
details of participants were also entered in the log if participants
consented to being contacted about future research. Selected
information from the study log at each clinical center was
securely transferred on a regular basis to the study management
center. At the study management center, contact details for
future research were kept securely and separately from the
questionnaire data.
Regular reports were sent from the study management center
to each site during the recruitment period, detailing trends and
overall progress in recruitment for each of the study sites. In
addition, regular checks were made on the completeness and
quality of the study log and its concordance with received
questionnaires.
Questionnaires received at the management center were digitized
by an external data processing contractor. Each paper
questionnaire was checked for legibility, digitally scanned, and
the resulting images were used as the source for two manual
data entry rounds with subsequent quality checking. The
completed data entry batches delivered by the contractor were
checked for accuracy at the study management center by fully
examining a 5% sample.
The original pseudonymized study datasets, including scanned
images of the questionnaires, were stored at the study
management center in encrypted digital form. They were
preserved by being duplicated and stored on managed servers
with regular backup and professional administration. The
original paper questionnaires were stored securely in locked
cabinets. The study datasets will be made freely and readily
available to the research community after a suitable interval in
a form that ensures that participant anonymity and
confidentiality is maintained.
Study Questionnaire
The questionnaire was based on the design of the ASTRA study
questionnaire, a cross sectional study that took place among
HIV positive participants attending outpatient HIV clinics across
the United Kingdom in 2011-2012 [37] that aimed to include a
representative sample of outpatients attending for care at each
center. The AURAH study questionnaire was adapted to capture
relevant information from HIV negative participants. An initial
questionnaire design was printed in A5 booklet format and
piloted at one study site in June 2013, using the recruitment
procedures described above. Following feedback from
participants and research staff, minor revisions were made to
the final questionnaire, the patient information sheet, the consent
form, and an insert was designed to attain further information
on preferences for HIV testing. These changes were submitted
as amendments for ethical approval and were incorporated into
the final version employed during the main recruitment period,
which commenced in July 2013.
The final questionnaire consisted of a printed A5 booklet, with
versions for men (24-page questionnaire) and women (20-page
questionnaire). The pilot study indicated that the questionnaire
took roughly 20-25 minutes to complete. The questionnaire
sought detailed information on the following factors:
1. Demographic and social factors: including gender, age or
year of birth, ethnicity, education, employment, housing,
financial status, sexuality, relationship status (whether in
long-term partnership and HIV-status of partner), country
of birth, and number of children.
2. Health and well-being: including psychological and physical
symptoms (modified version of Memorial Symptom
Assessment Scale Short-Form [43,44]), depression (PHQ-9
[42]), anxiety (Generalized Anxiety Disorder 7 [45]),
health-related quality of life (EuroQoL-3L [46]), and social
support (modified version of the Duke-UNC Functional
Social Support Questionnaire [47]).
3. Health and relevant medical history: including any major
medical conditions, recently diagnosed STIs, symptoms of
STIs, diagnosed hepatitis B and C, treatment for depression,
treatment for other mental health problems, pregnancy status
for women, and whether circumcised for men.
4. HIV-related information: including HIV status (participants
reporting HIV positive status on the questionnaire were
excluded from the study), history of any HIV tests, beliefs
about transmission risk in relation to ART and undetectable
VL, knowledge and history of use of PEP and PrEP, and
attitudes towards HIV self-testing and clinic based tests.
5. Lifestyle factors: including cigarette smoking status, usual
alcohol intake, evidence of alcohol dependency (the CAGE
questionnaire [48]), recent use of recreational drugs (with
details), and recent use of injecting drugs.
6. Sexual lifestyle: MSM participants were asked about
disclosure of their sexuality to others and involvement in
the gay social scene.
7. Sexual activity: sexual activity (vaginal or anal sex) during
the previous 3 months was ascertained separately for (i)
men having sex with women, (ii) men having sex with men,
and (iii) women having sex with men. For those participants
who reported condomless sex in the past 3 months, there
were questions on number of partners, type of partners
(long-term or other), attitudes to the risk of HIV infection,
and knowledge of the HIV status of partners. There were
additional questions on the number and type of partners if
the participant reported condomless sex with people known
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to be HIV positive. All participants were also asked about
the use of the Internet to find sexual partners, different sex
practices and group sex, attitudes towards disclosure of
HIV status to sexual partners and negotiation of condom
use, their total number of new sexual partners in the past
year, and preferred information sources (if any) about safer
sex.
8. HIV testing preferences: participants were asked to rank
different ways of testing for HIV. Ranking from least liked
to most appealing on a scale of 1-4, the options were (i) in
a sexual health clinic, (ii) general practitioner, (iii)
self-sampling, and (iv) self-testing. Participants were also
asked to indicate a preference for saliva or blood based
self-testing options.
Ethics Statement
The research protocol and all versions of the study documents
for the AURAH study (information sheet, consent form,
questionnaires and insert) were approved by the designated
Research Ethics Committees (REC) (National Research Ethics
Service committee London-Hampstead, ref: 13/LO/0246). Based
on these documents, the study subsequently received permission
for clinical research at all participating National Health Service
(NHS) sites from local Research & Development (R&D). The
REC (NRES committee London-Hampstead) further approved
the protocol and study documents for the AURAH2 study in
December 2014 (REC ref: 14/LO/1881) and subsequent
permission by local R&D for clinical research at the three NHS
clinic sites in March 2015.
Study Management
The study was managed on a day-to-day basis by a core group
of five staff at the study management center: the HIV
Epidemiology and Biostatistics Group, Research Department
of Infection and Population Health, Royal Free Campus,
University College London.
An advisory group was also established at the start of the study
to provide guidance and support. The advisory group consisted
of representatives from University College London, HIV i-Base,
the London School of Hygiene and Tropical Medicine and City
University London.
Results
Over the 17-month study period a total of 4393 eligible patients
were approached and asked to participate in this study. Of those
approached, 3340 (76.03%) gave consent to take part in the
study. The number of completed questionnaires finally collected
was 2630 and thus the response rate was 59.87% (2630/4393)
of eligible patients approached, and 78.74% (2630/3340) of
those who gave consent. The majority of respondents
(1432/2630, 54.44%) agreed to provide their contact details for
participation in future research.
Eighteen of the 20 participating clinics were able to provide
estimates of the number of outpatients seen in all clinical
sessions over the same period, and the numbers of these in the
key groups (MSM and black Africans). More than 288,090
patients were found to have attended these 18 clinics at some
point during the respective recruitment periods. Of the combined
total attending the clinics, it was estimated that approximately
7.6% were black African and 13.6% were MSM. Table 1 shows
the patient population (recruited to AURAH) and response rates
for the 20 clinical centers.
Characteristics of Those Recruited
The mean age (of the 2630 participants who supplied details)
at the time of questionnaire completion was 32 years (SD 10,
range 18-80 years). Overall, 1954 (74.30%) participants were
men and 676 (25.70%) were women. Of the 1939 male
participants whose sexuality was known, 1484 (76.53%)
self-classified as MSM and 455 (23.47%) as heterosexual. Of
the 1484 MSM participants, 965 (65.03%) agreed to provide
their contact details for participation in future research, whereas
only 36.92% (168/455) of heterosexual males and 43.20%
(292/676) of females agreed to provide these details.
In terms of ethnic origin, 1505 of the 2630 (57.22%) participants
self-classified as white, 580 participants (22.05%) as black
African ethnicity, 249 (9.47%) as other black ethnicity, 264
(10.04%) as other ethnicity, and ethnic status was missing for
32 (1.22%). Of 548 people of black African ethnicity, 323
(58.9%) were female and 225 (41.1%) were male. Of 250 men
of black African ethnicity whose sexuality was known, 30
(12.0%) self-classified as MSM and 220 (88.0%) as
heterosexual. Of the 580 participants of black African ethnicity,
213 (36.7%) agreed to provide contact details for participation
in future research.
Overall, 2535 of the 3340 consenting participants (75.90%)
took an HIV test on the day they were approached in clinic. Of
those tested, 18 of 2535 (0.71%) received a positive result that
they were unaware of at the time. Of these 18 participants, nine
returned completed questionnaires (these are retained in the
AURAH sample). All nine of these cases were male, of which
five were MSM and four were black heterosexuals. Clinics
reported that 2624 of the 3340 consenting (78.56%) also tested
for STIs on the day, although information on the nature of each
test and the results were not collected for this study.
The characteristics of those recruited at the 20 clinical centers
in terms of gender, sexual orientation, relevant ethnic status and
testing are detailed in Table 2.
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Table 1. Recruitment results for the 20 AURAH study clinical centers, 2013-2014.
Patients responding = complet-
ed questionnaires received (as
% of approached = response
rate)
Patients consenting (as
% of approached =
consent rate)
Eligible patients
approached
Individual patients
attending during
recruitment period
Length of study
period in days
Site
34 (53%)59 (92%)643475335Barking
11 (69%)13 (81%)16a31Barts
33 (62%)49 (92%)53a127Birmingham
227 (93%)240 (99%)24313918c482Brighton
55 (93%)58 (98%)591021312Bristol
73 (79%)82 (89%)9213662428Calderdale & Huddersfield
246 (91%)256 (95%)269b11218337Coventry
604 (44%)895 (65%)138451882d473Dean Street
123 (77%)149 (94%)15925312300Homerton
84 (36%)131 (56%)23520236d450John Hunter
168 (55%)204 (67%)30515500283Kings
48 (70%)66 (96%)69517384Leicester
313 (82%)370 (97%)38213652e332Mortimer Market
113 (67%)119 (71%)1689203320Newham
75 (91%)75 (91%)8214807405Reading
101 (74%)126 (92%)13733216416Royal Free
81 (74%)90 (82%)11017041333St George's
33 (83%)35 (88%)4013747247The London
164 (35%)270 (58%)46219094d463WLCSH
44 (69%)53 (83%)645933314Whipps Cross
2630 (60%)3340 (76%)4393288090-TOTALS
aClinic unable to supply data on total clinic attendance
bClinic was unable to supply data about those declining to participate – value derived from 95% consent rate estimated by the clinic
cCovers 75% of the recruitment period only
dCovers 90% of the recruitment period only
eCovers 55% of the recruitment period only
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Table 2.
STI test on the
day (as % of
consenting)
Tested for
HIV on the
day (as % of
consenting)
Black African
women (as % of
questionnaires re-
ceived)
Women (as % of
questionnaires re-
ceived)
Black African
men (as % of
questionnaires re-
ceived)
MSM (as % of
questionnaires re-
ceived)
Men (as % of
questionnaires re-
ceived)
Site label
49 (83%)43 (73%)9 (26%)9 (26%)16 (47%)8 (24%)25 (74%)Barking
13 (100%)13 (100%)0 (0%)0 (0%)0 (0%)11 (100%)11 (100%)Barts
49 (100%)40 (82%)3 (9%)22 (67%)0 (0%)7 (21%)11 (33%)Birmingham
185 (77%)170 (71%)9 (4%)20 (9%)5 (2%)197 (87%)207 (91%)Brighton
38 (66%)55 (95%)3 (5%)4 (7%)2 (4%)44 (80%)51 (93%)Bristol
71 (87%)69 (84%)11 (15%)18 (25%)6 (8%)47 (64%)55 (75%)Calderdale &
Huddersfield
161 (63%)124 (48%)105 (43%)142 (58%)57 (23%)34 (14%)104 (42%)Coventry
618 (69%)762 (85%)7 (1%)19 (3%)14 (2%)528 (87%)585 (97%)Dean Street
122 (82%)88 (59%)19 (15%)53 (43%)8 (7%)37 (30%)70 (57%)Homerton
98 (75%)94 (72%)1 (1%)15 (18%)4 (5%)49 (58%)69 (82%)John Hunter
164 (80%)136 (67%)25 (15%)103 (61%)13 (8%)31 (18%)65 (39%)Kings
54 (82%)50 (76%)11 (23%)34 (71%)2 (4%)8 (17%)14 (30%)Leicester
328 (89%)323 (87%)7 (2%)10 (3%)28 (9%)266 (85%)303 (97%)Mortimer
Market
113 (95%)98 (82%)41 (36%)52 (46%)50 (44%)7 (6%)61 (54%)Newham
68 (91%)64 (85%)16 (21%)25 (33%)8 (11%)35 (47%)50 (67%)Reading
116 (92%)98 (78%)16 (16%)60 (59%)6 (6%)29 (29%)41 (41%)Royal Free
82 (91%)65 (72%)7 (9%)25 (31%)10 (12%)36 (44%)56 (69%)St George's
35 (100%)26 (74%)14 (42%)16 (48%)5 (15%)10 (30%)17 (52%)The London
210 (78%)169 (63%)3 (2%)30 (18%)7 (4%)92 (56%)134 (82%)WLCSH
50 (94%)48 (91%)18 (41%)19 (43%)14 (32%)8 (18%)25 (57%)Whipps Cross
2624 (79%)2535 (76%)325 (12%)676 (26%)255 (10%)1484 (56%)1954 (74%)TOTALS
Discussion
The AURAH study recruited 2630 participants from 20 UK
sexual health clinics during 2013-2014. The initial rate for
consent (2630/3340, 78.74%) was relatively high in this study,
and the overall response rate (questionnaires received) was
59.87% (2630/4393) of eligible patients approached. However,
there was considerable variation between the clinics in the
response rate achieved (ranging from 35% to 93%). The
difference in response rates between the clinics could be due to
a number of reasons. When researchers at the sites with low
response rates were asked about potential barriers to
participation they noted education and literacy levels, level of
English fluency, and the perceived amount of time that the study
questionnaire would take to complete, among clinic attendees
at their sites. It was felt that the monthly prize draw had not had
a significant effect as an incentive to participate but potentially
a smaller cash sum might have, however the study did not seek
ethical approval for this due to time restraints.
The intention of this study was also to recruit large numbers
within the key demographic sub-groups most affected by HIV
in the United Kingdom, namely MSM and black African men
and women. The study succeeded in this aim, and there were
2034 individuals in these groups of interest: 1484 MSM
participants and 580 black African participants, with 30
individuals (1.47%) falling into both of these categories.
It is difficult to compare the overall study response rate with
other studies of HIV negative MSM, as many Internet or
venue-based studies have no records of numbers not agreeing
to participate, and therefore response rate cannot be calculated.
Our response rate is comparable with other surveys taking place
outside the clinical context that have investigated sexual
behavior (70% [49]; 65% [50]), and with the previous ASTRA
study on HIV positive patients whose response rate was 64%
[37]. Many of the 1746 non-responding eligible patients were
those who directly refused to participate (1036/1746, 59.34%).
However, the remaining 710 were consenting participants who
took a questionnaire away but did not return it (710/1746,
40.66% of non-responders). Although the option of taking a
questionnaire off-site for completion was intended to maximize
participation, some of the non-response in this study can be
attributed to factors impacting upon questionnaire completion
and postage after the questionnaires had been taken away from
the study site. For example, lack of time or continued motivation
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to complete and post the questionnaire. However, overall the
consent rate was slightly lower than in the comparable ASTRA
study and this may reflect the differences between the respective
clinic populations in terms of potential ongoing engagement
with care, and familiarity with the clinic research staff among
those attending HIV and general sexual health clinics.
The average age of AURAH study participants was 32 years
and, as expected, this was much younger than the average (45
years) of the ASTRA (HIV diagnosed) study participants [37].
The lower mean age for AURAH is consistent with the study’s
intention to sample from large numbers of currently HIV
negative but at risk individuals, who could be expected to be
younger than the HIV positive population.
The study population was not a random sample of those
attending the clinics, as targeted recruitment was implemented
after 6 months of recruitment. It should be noted that the target
number for MSM recruitment (1000) was exceeded and that the
target was reached early in the study. Recruitment was continued
because it was desirable to increase power for some research
questions. The number of black Africans recruited was 548,
however this took a long time to achieve and required selective
recruitment in 15 centers. A similar pattern of relative difficulty
of recruitment in these two respective populations was observed
in the ASTRA study (on HIV diagnosed individuals) [37] where
it was found that MSM were over-represented in its sample in
relation to the national HIV positive population, and conversely
black Africans were under-represented. However, the relative
difficulty of recruitment in AURAH may also be a reflection
of the different proportions within the populations attending the
sexual health clinics, with the overall proportion of MSM
(13.6%) being almost double the proportion of black Africans
(7.6%).
The number of study participants diagnosed as HIV positive
in-clinic during this study was 18 (0.71%, 95% CI 0.38-1.04,
of 2535 consenting and tested). The selective nature of our
sampling means this is not a meaningful prevalence estimate
but, as might be expected in those attending sexual health
clinics, this is very much higher than the general UK population
HIV estimate for undiagnosed HIV of 0.07% [1]. However, it
should be noted that in those identifying as MSM, there were
5 HIV positive cases out of 1484 (0.34%, 95% CI 0.04-0.63)
in this study, which is a relatively low value when compared
with the estimated 0.94% for the prevalence of undiagnosed
HIV in the UK MSM population as a whole [1]. This could
reflect the fact that MSM who regularly attend STI clinics are
likely to test more frequently for HIV than MSM in the United
Kingdom overall.
Conclusions
In summary, the AURAH study includes a substantive but
selective sample of those considered to be at risk of being
infected with HIV in the United Kingdom. AURAH will give
insights into the relationships between socio-demographic
factors, physical and psychological symptoms, lifestyle factors,
health-related quality of life, and sexual behavior in this
population.
The results of the AURAH study will be relevant for
understanding the process of HIV transmission within the United
Kingdom, and for targeting of national prevention efforts. The
data from AURAH will contribute to understanding the social,
psychological and health-related factors that are linked to high
risk sexual and HIV-testing behaviors, and therefore to ongoing
transmission of HIV in the two most at risk groups of people
in the United Kingdom.
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